Emotional regulation enhancement

"Emotional regulation enhancement" is not a specific molecule, receptor, or canonical therapeutic target. Instead, it refers to the process or outcome of improving an individual's ability to modulate their emotional responses through intrinsic (internal) and extrinsic (external) mechanisms. Emotional regulation involves complex neural circuits—primarily the prefrontal cortex, amygdala, anterior cingulate cortex, and related neurotransmitter systems such as serotonin and dopamine—that underlie the initiation, inhibition, or modulation of emotions in response to environmental demands. Enhancing emotion regulation can be achieved through behavioral interventions like cognitive-behavioral therapy (CBT), mindfulness-based interventions (MBIs), and other psychotherapeutic approaches that promote neuroplasticity in relevant brain regions. These changes are associated with improved mental health outcomes and resilience against stress-related disorders but do not correspond to a single molecular entity or druggable target. Because "emotional regulation enhancement" describes a functional outcome rather than a discrete biological molecule or receptor classifiable as a therapeutic target (such as an enzyme or receptor), it is considered incorrect for use as a canonical drug discovery target.

Other names

Emotional regulation enhancementEmotion regulation improvementEnhancement of emotional self-regulation